172 related articles for article (PubMed ID: 1316079)
1. A double-blind study of two dosage regimens of lomefloxacin in bacteriologically proven exacerbations of chronic bronchitis of gram-negative etiology.
Kemper P; Köhler D
Am J Med; 1992 Apr; 92(4A):98S-102S. PubMed ID: 1316079
[TBL] [Abstract][Full Text] [Related]
2. Safety and efficacy of lomefloxacin versus cefaclor in the treatment of acute exacerbations of chronic bronchitis.
Gotfried MH; Ellison WT
Am J Med; 1992 Apr; 92(4A):108S-113S. PubMed ID: 1316059
[TBL] [Abstract][Full Text] [Related]
3. Lomefloxacin versus amoxicillin in the treatment of acute exacerbations of chronic bronchitis: an Italian multicenter study.
Grassi C; Albera C; Pozzi E
Am J Med; 1992 Apr; 92(4A):103S-107S. PubMed ID: 1316058
[TBL] [Abstract][Full Text] [Related]
4. Efficacy and safety of a 10-day course of 400 or 600 milligrams of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 milligrams of ciprofloxacin twice daily.
Chodosh S; Lakshminarayan S; Swarz H; Breisch S
Antimicrob Agents Chemother; 1998 Jan; 42(1):114-20. PubMed ID: 9449270
[TBL] [Abstract][Full Text] [Related]
5. Sparfloxacin vs ofloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis: a multicenter, double-blind, randomized, comparative study. Sparfloxacin Multicenter ABECB Study Group.
DeAbate CA; Henry D; Bensch G; Jubran A; Chodosh S; Harper L; Tipping D; Talbot GH
Chest; 1998 Jul; 114(1):120-30. PubMed ID: 9674458
[TBL] [Abstract][Full Text] [Related]
6. Effectiveness of short-course therapy (5 days) with grepafloxacin in the treatment of acute bacterial exacerbations of chronic bronchitis.
DeAbate CA; Bettis R; Munk ZM; Fleming H; Munn NJ; Riffer E; Bagby B; Giguere G; Collins JJ
Clin Ther; 1999 Jan; 21(1):172-88. PubMed ID: 10090434
[TBL] [Abstract][Full Text] [Related]
7. Double-blind, comparative study of rufloxacin once daily versus amoxicillin three times a day in treatment of outpatients with exacerbations of chronic bronchitis.
Klietmann W; Cesana M; Rondel RK; Focht J
Antimicrob Agents Chemother; 1993 Nov; 37(11):2298-306. PubMed ID: 8285609
[TBL] [Abstract][Full Text] [Related]
8. Safety and effectiveness of lomefloxacin in patients with acute exacerbation of chronic bronchitis (AECB) chronically treated with oral theophyllines.
Melani AS; Pirrelli M; Sarlo F; Cantoni V;
J Chemother; 2001 Dec; 13(6):628-34. PubMed ID: 11806624
[TBL] [Abstract][Full Text] [Related]
9. Treating acute bacterial exacerbations of chronic bronchitis in patients unresponsive to previous therapy: sparfloxacin versus clarithromycin.
Lipsky BA; Unowsky J; Zhang H; Townsend L; Talbot GH
Clin Ther; 1999 Jun; 21(6):954-65. PubMed ID: 10440620
[TBL] [Abstract][Full Text] [Related]
10. Infection in the elderly: studies with lomefloxacin.
Crome P; Bruce-Jones P
Am J Med; 1992 Apr; 92(4A):126S-129S. PubMed ID: 1316062
[TBL] [Abstract][Full Text] [Related]
11. The safety and efficacy of short course (5-day) moxifloxacin vs. azithromycin in the treatment of patients with acute exacerbation of chronic bronchitis.
DeAbate CA; Mathew CP; Warner JH; Heyd A; Church D
Respir Med; 2000 Nov; 94(11):1029-37. PubMed ID: 11127487
[TBL] [Abstract][Full Text] [Related]
12. Randomized, double-blind study of grepafloxacin versus amoxycillin in patients with acute bacterial exacerbations of chronic bronchitis.
Langan CE; Cranfield R; Breisch S; Pettit R
J Antimicrob Chemother; 1997 Dec; 40 Suppl A():63-72. PubMed ID: 9484875
[TBL] [Abstract][Full Text] [Related]
13. Randomized, double-blind study of prulifloxacin versus ciprofloxacin in patients with acute exacerbations of chronic bronchitis.
Grassi C; Salvatori E; Rosignoli MT; Dionisio P;
Respiration; 2002; 69(3):217-22. PubMed ID: 12097764
[TBL] [Abstract][Full Text] [Related]
14. Temafloxacin in acute purulent exacerbations of chronic bronchitis.
Davies BI; Maesen FP; Gubbelmans HL; Cremers HM
J Antimicrob Chemother; 1990 Aug; 26(2):237-46. PubMed ID: 2120178
[TBL] [Abstract][Full Text] [Related]
15. Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis.
Langan CE; Zuck P; Vogel F; McIvor A; Peirzchala W; Smakal M; Staley H; Marr C
J Antimicrob Chemother; 1999 Oct; 44(4):515-23. PubMed ID: 10588313
[TBL] [Abstract][Full Text] [Related]
16. Efficacy of lomefloxacin as compared to norfloxacin in the treatment of uncomplicated urinary tract infections in adults.
Iravani A
Am J Med; 1992 Apr; 92(4A):75S-81S. PubMed ID: 1316075
[TBL] [Abstract][Full Text] [Related]
17. Etiology, susceptibility, and treatment of acute bacterial exacerbations of complicated chronic bronchitis in the primary care setting: ciprofloxacin 750 mg b.i.d. versus clarithromycin 500 mg b.i.d. Bronchitis Study Group.
Anzueto A; Niederman MS; Tillotson GS
Clin Ther; 1998; 20(5):885-900. PubMed ID: 9829441
[TBL] [Abstract][Full Text] [Related]
18. A comparison of gemifloxacin and clarithromycin in acute exacerbations of chronic bronchitis and long-term clinical outcomes.
Wilson R; Schentag JJ; Ball P; Mandell L;
Clin Ther; 2002 Apr; 24(4):639-52. PubMed ID: 12017408
[TBL] [Abstract][Full Text] [Related]
19. The U.S. clinical experience with lomefloxacin, a new once-daily fluoroquinolone.
Rizk E
Am J Med; 1992 Apr; 92(4A):130S-135S. PubMed ID: 1316063
[TBL] [Abstract][Full Text] [Related]
20. Lomefloxacin versus norfloxacin in the treatment of uncomplicated urinary tract infections: three-day versus seven-day treatment. The South Swedish Lolex Study Group.
Neringer R; Forsgren A; Hansson C; Ode B
Scand J Infect Dis; 1992; 24(6):773-80. PubMed ID: 1337623
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
